Understanding clinical adoption: How a therapy is reimbursed.

A presentation by Nancy Sikich, MSc (Health Quality Ontario) at the Bench to Bedside for Biotherapeutics (B3) Workshop held in Toronto on October 5, 2017.

In this seminar, Nancy Sikich discusses the role of Health Quality Ontario (HQO) in assessing and implementing innovations within a healthcare framework. Through a series of examples, this seminar covers how health technologies are assessed, evaluated for adoption and the reimbursement pathway of new technologies.

This video is presented by the Clinical Translation Education Group:  BioCanRx, CCRM, CellCAN, Foundation Fighting Blindness, Ontario Institute for Cancer Research, Ontario Institute for Regenerative Medicine and Stem Cell Network.

All other pages contact

For more information, please contact us.
Font Resize
Enable Contrast